DISCLAIMER — Not financial advice. Educational content only, not an offer or solicitation to buy or sell any security. Biotech and small/mid-cap stocks are highly speculative and volatile and can result in a partial or total loss of capital. Do your own research and consult a licensed advisor where appropriate. / Contenuti a solo scopo informativo e didattico, non costituiscono consulenza finanziaria né offerta o sollecitazione al pubblico risparmio ai sensi delle normative CONSOB e SEC. Le azioni biotech e le small/mid cap sono strumenti altamente speculativi e volatili e possono comportare la perdita parziale o totale del capitale investito. Si raccomanda di effettuare sempre le proprie ricerche e, se necessario, di rivolgersi a un consulente abilitato.
Merlintrader Trading Pub
Biotech catalyst news and analysis. FDA PDUFA tracker
Merlintrader Trading Pub
Biotech catalyst news and analysis. FDA PDUFA tracker
OneMedNet Corporation
AI-Powered Real-World Data (RWD) Healthcare Platform | Palantir Partner
$2.15
▲ +$0.73 (+51.41%)
Last Update: November 28, 2025 10:38 AM ET | Source: Finviz
Open: $1.03
High: $2.24
Low: $1.02
Prev Close: $1.42
Volume: 15.55M (12.98x avg)
? Company Overview
OneMedNet Corporation (NASDAQ: ONMD) is a healthcare technology company specializing in curating and providing regulatory-grade Real-World Data (RWD) through its proprietary iRWD™ platform. The company connects life sciences organizations, medical device companies, and AI researchers with de-identified medical imaging, electronic health records, and clinical data.
Key Business Metrics
- Network Coverage: 2,130+ healthcare provider sites globally
- Patient Data: 47+ million unique patient lives
- Clinical Exams: 186+ million imaging studies (+37% YoY)
- Patient Records: +38% growth YoY
- Administrative Claims: 5+ billion claims data points
- Therapeutic Areas: Oncology, Cardiology, Rare Diseases, Neurology
- Employees: 22
- IPO Date: June 24, 2021
? Timeline: Key Developments 2021-2025
June 24, 2021
IPO Date – OneMedNet Corporation went public on NASDAQ.
October 25, 2023
All-Time High Reached – Stock reached ATH of $13.51 following business combination completion.
November 2023
Business Combination Completed – OneMedNet completed merger with Data Knights Acquisition Corp. Paul Casey served as CEO.
April 2024
Aaron Green Appointed CEO – Former Optum Insights VP Cloud Solutions takes leadership. Paul Casey retires, remains on Board of Directors.
June 2024
NASDAQ Compliance Notice – Company received notice for delayed Form 10-Q filing. Subsequently regained compliance.
November 2024
Bitcoin Treasury Strategy Launched – Announced investment in approximately 34 Bitcoin as strategic reserve.
April 22, 2025
52-Week Low Reached – Stock hit 52-week low of $0.30 amid cash concerns.
June 2025
$3.7M Private Placement + $11M Debt Reduction – Secured funding at $0.42/share.
July 2025
80% Debt Reduction Announced – Aggregate reductions of $14.3M YTD.
October 6, 2025
Palantir Partnership Announced – Multi-year collaboration with Palantir Technologies (NYSE: PLTR) to integrate AIP with iRWD™ network.
November 13, 2025
Q3 2025 10-Q Filed – SEC quarterly report filed showing improved net income due to debt gains.
November 17, 2025
Q3 Results: 815% Bookings Growth – Q3 2025 bookings of $1.1M (+815% YoY), 4.5x increase in inbound demand.
November 24, 2025
RSNA 2025 Platform Showcase – Demonstrating new Palantir-powered platform at RSNA Conference, Booth #1742, Chicago.
November 28, 2025
Stock Surges +51.41% – ONMD reaches $2.15 from $1.42 prev close with volume of 15.55M shares (12.98x avg), driven by insider buying news and RSNA momentum.
? Financial Position (Q3 2025 – SEC 10-Q Filing Nov 13, 2025)
| Metric | Q3 2025 | Q3 2024 | Change |
|---|---|---|---|
| Total Revenue | $177,000 | $142,000 | +24.6% |
| 9-Month Revenue (YTD) | $468,000 | $617,000 | -24.1% |
| Annual Sales (TTM) | $0.49M | N/A | – |
| Gross Margin | -160.81% | N/A | Negative |
| Operating Margin | -1,856.16% | N/A | Severely Negative |
| Profit Margin | -413.11% | N/A | Negative |
| Net Loss (Q3) | -$741,000 | -$2.06M | +64% Improved |
| Net Income (9-Month YTD) | +$339,000 | N/A | Profit (Debt Gains) |
| Q3 Bookings | $1.1M | $120K | +815% |
| EPS (TTM) | -$0.08 | N/A | Loss per share |
Balance Sheet (As of September 30, 2025)
| Asset/Liability | Value | Notes |
|---|---|---|
| Cash & Cash Equivalents | $149,000 | Very limited liquidity |
| Cash/Share | $0.01 | Minimal |
| Book Value/Share | -$0.08 | Negative book value |
| Bitcoin Holdings | ~$600,000 | 5 BTC units (reduced from 34) |
| Total Assets | $1.51M | – |
| Current Liabilities | $5.01M | Exceeds current assets |
| Stockholders’ Deficit | -$3.94M | Negative equity |
| YTD Liability Reduction | $14.3M | Significant deleveraging |
⚠️ Going Concern Warning
Per SEC 10-Q filing (November 13, 2025): The company has raised substantial doubt about its ability to continue as a going concern due to low cash reserves ($149K / $0.01 per share), negative gross margins (-160.81%), and current liabilities significantly exceeding current assets.
? Finviz Key Metrics (Nov 28, 2025 – 10:38 AM ET)
? Valuation
Market Cap$104.05M
Enterprise Value$103.69M
P/S (Price/Sales)212.36
P/C (Price/Cash)138.74
EV/Sales211.62
P/E, P/B, P/FCFN/A
? Ownership
Insider Ownership67.99%
Insider Trans (3M)+12.83%
Institutional Own29.81%
Inst Trans (3M)-53.48%
Shares Outstanding49.73M
Float16.33M
? Short Interest
Short Float0.73%
Short Ratio0.02
Short Interest0.12M shares
Options AvailableNo
ShortableYes
? Profitability
ROA-69.05%
ROEN/A
ROICN/A
Gross Margin-160.81%
Oper. Margin-1,856.16%
Profit Margin-413.11%
? Performance
Perf Week+67.16%
Perf Month-13.92%
Perf Quarter+137.21%
Perf Half Year+410.00%
Perf YTD+50.00%
Perf Year+123.93%
? Technical Indicators
SMA20+34.01%
SMA50+13.75%
SMA200+129.08%
RSI (14)61.08
ATR (14)0.28
Beta1.14
? Strategic Partnership: Palantir Technologies
On October 6, 2025, OneMedNet announced a multi-year collaboration with Palantir Technologies (NYSE: PLTR) to integrate Palantir’s Artificial Intelligence Platform (AIP) and Foundry with the iRWD™ network.
Partnership Capabilities
- Faster Data Discovery: Minutes instead of days/weeks for cohort feasibility
- AI-Driven De-identification: Large-scale data anonymization
- Healthcare Standards Integration: SNOMED, HCPCS, ICD-10, CPT codes
- Federated Search: Cross-network multimodal data queries
- Natural Language Search: AI-powered conversational queries
- SaaS Subscription Model: Live Data Feeds + recurring revenue
“This is transformational — what used to take days of effort now takes minutes, with better accuracy.” — Senior Executive at leading evidence generation firm (ISPOR Europe)
? CEO Profile: Aaron Green
Aaron Green
Position: President & Chief Executive Officer (since April 2024)
Experience: 20+ years in healthcare IT leadership
Previous Roles:
- VP Cloud Solutions – Optum Insights (UnitedHealth Group)
- SVP & General Manager, Radiology/Cardiology – Change Healthcare (2017-2019)
- Division VP, Sales – McKesson Corporation
- President – OneMedNet (May 2023 – April 2024)
Key Achievements at OneMedNet:
- Nearly doubled clinical data network in 2024
- Secured Palantir strategic partnership
- Led 815% bookings growth in Q3 2025
- Executed $14.3M debt reduction program
- Launched SaaS subscription revenue model
? Management Team & Governance
| Name | Position |
|---|---|
| Aaron Green | President, CEO & Director |
| Dr. Jeffrey Yu, M.D. | Founder, Chairman, VP & Chief Medical Officer |
| Robert L. Golden | CFO, Corporate Secretary & Director |
| James Wang | Chief Technology Officer |
| Steven Chartier | VP of Engineering & Chief of Data |
| Michael Wong | VP of Marketing |
| Paul Casey | Board Member (Former CEO) |
? Insider Buying – Today’s Catalyst!
Per Finviz (Nov 28): “Recent insider buying disclosures ignited a 45% intraday surge amid retail buzz.”
Insider Ownership: 67.99% (very high)
Insider Transactions (3M): +12.83% (net buying)
? Upcoming Catalysts
| Catalyst | Expected Date | Potential Impact |
|---|---|---|
| RSNA 2025 Conference | Nov 24-28, 2025 (NOW) | Platform demos, visibility |
| Palantir Integration Updates | Q4 2025 – Q1 2026 | Full SaaS rollout |
| Next Earnings Report | ~December 2025 | Bookings conversion |
| SaaS ARR Milestones | 2026 | Recurring revenue |
| Capital Raise / Dilution | Near-term likely | Cash constraints |
? Technical Analysis (November 28, 2025 – Finviz)
Current Price
$2.15
+$0.73 (+51.41%)
Volume Today
15.55M
Rel Vol: 12.98x
Avg Volume
5.82M
Daily Average
RSI (14)
61.08
Neutral-Bullish
Beta
1.14
Market Correlation
Volatility
15.81%/12.60%
Week / Month
Technical Levels to Watch
| Level Type | Price |
|---|---|
| Today’s High | $2.24 |
| Today’s Low | $1.02 |
| Open | $1.03 |
| Previous Close | $1.42 |
| Current Price | $2.15 (+51.41%) |
| Analyst Target Price | $1.42 |
| 52-Week High | $4.22 (-49.05% from current) |
| 52-Week Low | $0.30 (+616.67% from low) |
| SMA 20 | +34.01% above |
| SMA 50 | +13.75% above |
| SMA 200 | +129.08% above |
Technical Summary
Trend: STRONG BULLISH – Price above all major SMAs
RSI (14): 61.08 – Bullish but not overbought
Volume: 12.98x relative volume – Extreme interest
Momentum: +67.16% weekly, +137.21% quarterly, +410% half-year
vs Target: Trading at $2.15 vs $1.42 analyst target (+51% premium)
⚠️ Extreme Volatility Warning
ONMD surged +51.41% in a single session (from $1.42 to $2.15) with volume 12.98x average. Currently trading 51% above analyst target ($1.42). Extreme risk of pullback. NOT suitable for risk-averse investors.
? Bull vs Bear Case
? BULL CASE
- Palantir partnership = institutional validation
- 815% bookings growth Q3 2025
- $14.3M debt reduction
- $868B AI healthcare market by 2030
- SaaS recurring revenue transition
- 67.99% insider ownership
- +12.83% insider buying (3M)
- 4.5x inbound demand increase
- +410% 6-month performance
- Low short interest (0.73%)
? BEAR CASE
- Going concern warning (SEC)
- Only $149K cash ($0.01/share)
- Negative book value (-$0.08/share)
- Stockholders’ deficit -$3.94M
- Gross margin: -160.81%
- Operating margin: -1,856.16%
- ROA: -69.05%
- Revenue declining YoY (-24%)
- Trading 51% above target ($1.42)
- -53.48% institutional selling (3M)
- 84% below ATH ($13.51)
OneMedNet Corporation
Piattaforma AI per Real-World Data (RWD) Sanitari | Partner di Palantir
$2,15
▲ +$0,73 (+51,41%)
Ultimo Aggiornamento: 28 Novembre 2025 10:38 AM ET | Fonte: Finviz
Open: $1,03
High: $2,24
Low: $1,02
Prev Close: $1,42
Volume: 15,55M (12,98x media)
? Panoramica Aziendale
OneMedNet Corporation (NASDAQ: ONMD) è una società di tecnologia sanitaria specializzata nella cura e fornitura di Real-World Data (RWD) di grado regolatorio attraverso la sua piattaforma proprietaria iRWD™. L’azienda collega organizzazioni life sciences, produttori di dispositivi medici e ricercatori AI con imaging medico de-identificato, cartelle cliniche elettroniche e dati clinici.
Metriche Chiave del Business
- Copertura Network: 2.130+ siti di fornitori sanitari globali
- Dati Pazienti: 47+ milioni di vite paziente uniche
- Esami Clinici: 186+ milioni di studi imaging (+37% YoY)
- Cartelle Cliniche: +38% crescita YoY
- Claims Amministrativi: 5+ miliardi di data points
- Aree Terapeutiche: Oncologia, Cardiologia, Malattie Rare, Neurologia
- Dipendenti: 22
- Data IPO: 24 Giugno 2021
? Timeline: Sviluppi Chiave 2021-2025
24 Giugno 2021
Data IPO – OneMedNet Corporation quotata su NASDAQ.
25 Ottobre 2023
Massimo Storico Raggiunto – Titolo raggiunge ATH di $13,51.
Novembre 2023
Business Combination Completata – OneMedNet completa fusione con Data Knights Acquisition Corp.
Aprile 2024
Aaron Green Nominato CEO – L’ex VP Cloud Solutions di Optum Insights assume la leadership.
Giugno 2024
Avviso Compliance NASDAQ – Ricevuto avviso per ritardo nel deposito del Form 10-Q.
Novembre 2024
Strategia Treasury Bitcoin – Investimento in circa 34 Bitcoin come riserva strategica.
22 Aprile 2025
Minimo 52 Settimane – Titolo tocca minimo di $0,30.
Giugno 2025
$3,7M Private Placement + $11M Riduzione Debito
Luglio 2025
Riduzione Debito 80% – Riduzioni aggregate di $14,3M YTD.
6 Ottobre 2025
Partnership Palantir – Collaborazione pluriennale con Palantir Technologies.
13 Novembre 2025
10-Q Q3 2025 Depositato – Report trimestrale SEC.
17 Novembre 2025
Risultati Q3: +815% Bookings – Bookings Q3 di $1,1M, aumento 4,5x domanda.
24 Novembre 2025
RSNA 2025 – Showcase piattaforma Palantir, Booth #1742, Chicago.
28 Novembre 2025
Titolo Esplode +51,41% – ONMD da $1,42 a $2,15 con volume 15,55M (12,98x media).
? Posizione Finanziaria (Q3 2025 – SEC 10-Q 13 Nov 2025)
| Metrica | Q3 2025 | Q3 2024 | Variazione |
|---|---|---|---|
| Ricavi Totali | $177.000 | $142.000 | +24,6% |
| Ricavi 9 Mesi (YTD) | $468.000 | $617.000 | -24,1% |
| Vendite Annuali (TTM) | $0,49M | N/A | – |
| Margine Lordo | -160,81% | N/A | Negativo |
| Margine Operativo | -1.856,16% | N/A | Gravemente Neg. |
| Margine Profitto | -413,11% | N/A | Negativo |
| Perdita Netta (Q3) | -$741.000 | -$2,06M | +64% Migliorata |
| Utile Netto (9M YTD) | +$339.000 | N/A | Gain su Debito |
| Bookings Q3 | $1,1M | $120K | +815% |
| EPS (TTM) | -$0,08 | N/A | Perdita |
Stato Patrimoniale (Al 30 Settembre 2025)
| Asset/Passività | Valore | Note |
|---|---|---|
| Cassa e Equivalenti | $149.000 | Liquidità limitata |
| Cassa/Azione | $0,01 | Minima |
| Book Value/Azione | -$0,08 | Negativo |
| Bitcoin in Portafoglio | ~$600.000 | 5 BTC |
| Totale Attivo | $1,51M | – |
| Passività Correnti | $5,01M | Superiori attività |
| Deficit Patrimonio Netto | -$3,94M | Negativo |
| Riduzione Passività YTD | $14,3M | Deleveraging |
⚠️ Avviso Going Concern
Da SEC 10-Q (13 Novembre 2025): La società ha sollevato dubbi sostanziali sulla sua capacità di continuare come azienda in funzionamento per scarse riserve di cassa ($149K / $0,01/azione), margini lordi negativi (-160,81%) e passività correnti che superano le attività correnti.
? Metriche Chiave Finviz (28 Nov 2025 – 10:38 AM ET)
? Valutazione
Market Cap$104,05M
Enterprise Value$103,69M
P/S212,36
P/C138,74
EV/Sales211,62
P/E, P/B, P/FCFN/A
? Ownership
Insider Ownership67,99%
Insider Trans (3M)+12,83%
Institutional Own29,81%
Inst Trans (3M)-53,48%
Azioni Outstanding49,73M
Float16,33M
? Short Interest
Short Float0,73%
Short Ratio0,02
Short Interest0,12M azioni
Opzioni DisponibiliNo
ShortabileSì
? Profittabilità
ROA-69,05%
ROEN/A
ROICN/A
Margine Lordo-160,81%
Margine Oper.-1.856,16%
Margine Profitto-413,11%
? Performance
Perf Settimana+67,16%
Perf Mese-13,92%
Perf Trimestre+137,21%
Perf Semestre+410,00%
Perf YTD+50,00%
Perf Anno+123,93%
? Indicatori Tecnici
SMA20+34,01%
SMA50+13,75%
SMA200+129,08%
RSI (14)61,08
ATR (14)0,28
Beta1,14
? Partnership Strategica: Palantir Technologies
Il 6 ottobre 2025, OneMedNet ha annunciato una collaborazione pluriennale con Palantir Technologies (NYSE: PLTR) per integrare la Piattaforma di Intelligenza Artificiale (AIP) e Foundry con il network iRWD™.
Capacità della Partnership
- Data Discovery più Veloce: Minuti invece di giorni/settimane
- De-identificazione AI-Driven: Anonimizzazione su larga scala
- Integrazione Standard Sanitari: SNOMED, HCPCS, ICD-10, CPT
- Ricerca Federata: Query dati multimodali cross-network
- Ricerca in Linguaggio Naturale: Query AI-powered
- Modello Subscription SaaS: Live Data Feeds + ricavi ricorrenti
? Profilo CEO: Aaron Green
Aaron Green
Posizione: President & CEO (da Aprile 2024)
Esperienza: 20+ anni in IT sanitario
Ruoli Precedenti:
- VP Cloud Solutions – Optum Insights (UnitedHealth Group)
- SVP & GM, Radiology/Cardiology – Change Healthcare (2017-2019)
- Division VP, Sales – McKesson Corporation
- President – OneMedNet (Mag 2023 – Apr 2024)
Risultati Chiave:
- Raddoppiato network dati clinici nel 2024
- Ottenuta partnership Palantir
- Guidato crescita bookings +815% Q3 2025
- Eseguito riduzione debito $14,3M
- Lanciato modello SaaS subscription
? Management Team & Governance
| Nome | Posizione |
|---|---|
| Aaron Green | President, CEO & Director |
| Dr. Jeffrey Yu, M.D. | Fondatore, Chairman, VP & CMO |
| Robert L. Golden | CFO, Corporate Secretary & Director |
| James Wang | Chief Technology Officer |
| Steven Chartier | VP Engineering & Chief of Data |
| Michael Wong | VP Marketing |
| Paul Casey | Board Member (Ex CEO) |
? Acquisti Insider – Catalyst di Oggi!
Da Finviz (28 Nov): “Recenti disclosure di acquisti insider hanno innescato un surge intraday del 45% in mezzo al buzz retail.”
Insider Ownership: 67,99% (molto alto)
Transazioni Insider (3M): +12,83% (acquisti netti)
? Prossimi Catalyst
| Catalyst | Data Prevista | Impatto |
|---|---|---|
| Conferenza RSNA 2025 | 24-28 Nov 2025 (ORA) | Demo, visibilità |
| Integrazione Palantir | Q4 2025 – Q1 2026 | Rollout SaaS |
| Prossimo Earnings | ~Dicembre 2025 | Conversione bookings |
| Milestone ARR SaaS | 2026 | Ricavi ricorrenti |
| Aumento Capitale | Breve termine | Vincoli cassa |
? Analisi Tecnica (28 Novembre 2025 – Finviz)
Prezzo Attuale
$2,15
+$0,73 (+51,41%)
Volume Oggi
15,55M
Vol Rel: 12,98x
Volume Medio
5,82M
Media Giornaliera
RSI (14)
61,08
Neutro-Rialzista
Beta
1,14
Correlazione Mercato
Volatilità
15,81%/12,60%
Sett / Mese
Livelli Tecnici da Monitorare
| Tipo Livello | Prezzo |
|---|---|
| Massimo Oggi | $2,24 |
| Minimo Oggi | $1,02 |
| Apertura | $1,03 |
| Chiusura Precedente | $1,42 |
| Prezzo Attuale | $2,15 (+51,41%) |
| Target Price Analisti | $1,42 |
| Massimo 52 Settimane | $4,22 (-49,05% dal corrente) |
| Minimo 52 Settimane | $0,30 (+616,67% dal minimo) |
| SMA 20 | +34,01% sopra |
| SMA 50 | +13,75% sopra |
| SMA 200 | +129,08% sopra |
Riepilogo Tecnico
Trend: FORTEMENTE RIALZISTA – Prezzo sopra tutte le SMA
RSI (14): 61,08 – Rialzista ma non ipercomprato
Volume: 12,98x volume relativo – Interesse estremo
Momentum: +67,16% sett, +137,21% trim, +410% sem
vs Target: Trading a $2,15 vs $1,42 target (+51% premio)
⚠️ Avviso Volatilità Estrema
ONMD è salito del +51,41% in una singola sessione (da $1,42 a $2,15) con volume 12,98x media. Attualmente trading 51% sopra target analisti ($1,42). Rischio estremo di pullback. NON adatto a investitori avversi al rischio.
? Caso Bull vs Bear
? CASO RIALZISTA
- Partnership Palantir = validazione
- Bookings +815% Q3 2025
- Riduzione debito $14,3M
- Mercato AI sanitario $868B 2030
- Transizione ricavi SaaS
- 67,99% insider ownership
- +12,83% acquisti insider (3M)
- 4,5x aumento domanda
- +410% performance 6 mesi
- Short interest basso (0,73%)
? CASO RIBASSISTA
- Avviso going concern (SEC)
- Solo $149K cash ($0,01/az)
- Book value negativo (-$0,08/az)
- Deficit patrimonio -$3,94M
- Margine lordo: -160,81%
- Margine operativo: -1.856,16%
- ROA: -69,05%
- Ricavi in calo YoY (-24%)
- Trading 51% sopra target ($1,42)
- -53,48% vendite istituzionali (3M)
- 84% sotto ATH ($13,51)
⚠️ DISCLAIMER / AVVERTENZE
ENGLISH: This report is for informational and educational purposes only and does not constitute financial, investment, or trading advice. The author and Merlintrader are NOT registered investment advisors, brokers, or financial professionals. All information is based on publicly available sources including SEC filings, Globe Newswire, and Finviz. No guarantee is provided regarding accuracy or timeliness.
RISK WARNING: OneMedNet (ONMD) is a micro-cap/penny stock with significant risks: going concern warnings, limited liquidity ($0.01 cash/share), negative book value (-$0.08/share), extreme volatility. The stock moved +51.41% intraday and is trading 51% above analyst target. NOT suitable for risk-averse investors.
DISCLOSURE: The author may or may not hold positions in ONMD. This is not a recommendation to buy, sell, or hold any security.
ITALIANO: Questo report è solo a scopo informativo ed educativo e non costituisce consulenza finanziaria, di investimento o di trading. L’autore e Merlintrader NON sono consulenti finanziari registrati. Tutte le informazioni sono basate su fonti pubbliche inclusi SEC filings, Globe Newswire e Finviz. Non viene fornita alcuna garanzia riguardo all’accuratezza.
AVVISO DI RISCHIO: OneMedNet (ONMD) è un titolo micro-cap/penny stock con rischi significativi: avvisi going concern, liquidità limitata ($0,01 cash/azione), book value negativo (-$0,08/azione), volatilità estrema. Il titolo ha registrato +51,41% intraday ed è trading 51% sopra il target analisti. NON adatto a investitori avversi al rischio.
DISCLOSURE: L’autore potrebbe o meno detenere posizioni in ONMD. Questa non è una raccomandazione ad acquistare, vendere o detenere alcun titolo.
Data Sources: SEC EDGAR, Globe Newswire, Finviz
Report Date: November 28, 2025
Price Data: $2.15 (+51.41% from $1.42 prev close) @ 10:38 AM ET – Finviz
OHLC: O: $1.03 | H: $2.24 | L: $1.02 | PC: $1.42
Author: Merlintrader.com
© 2025 Merlintrader – All Rights Reserved
Scanner for active traders
Try ChartsWatcher free, then unlock 10% OFF with SAVE10
ChartsWatcher is a real-time scanner for momentum traders: fast movers, unusual volume and rotations — so you can focus on the few tickers that matter right now, instead of watching hundreds of charts.
Start with the free version. When you upgrade, use SAVE10 for 10% OFF your first paid period.
Start free – then use SAVE10
No credit card required to start. Apply SAVE10 when upgrading.
Recommended platform
One platform. All your brokers.
Medved Trader connects multiple brokers in one workspace, with pro charts, hotkeys and fast execution — without changing your broker accounts.
A single cockpit for positions, Level II and multi-broker order routing, built for active day & swing traders.
Get 1 Month Free ➔
Multi-broker workflow + customizable layouts in one platform.
Monica.im – the AI assistant I use every day
If you find value in the work I publish on Merlintrader and want a practical AI assistant for research and writing, you can sign up using this referral link. Click here to try Monica.im and support the site
Find out how I use AI on Merlintrader: AI, retail and Merlintrader
Disclosure: some of the links in the promotional blocks above are affiliate or referral links. If you choose to subscribe or sign up through them, Merlintrader may receive a small commission or benefit at no extra cost to you.
